Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Sepsis Diagnostic Market, By Technology
7.1. Sepsis Diagnostic Market, By Technology Type, 2020-2027
7.1.1. Microbiology
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Molecular Diagnostics
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Immunoassays
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Flow Cytometry
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Sepsis Diagnostic Market, Pathogen
8.1. Sepsis Diagnostic Market, Pathogen, 2020-2027
8.1.1. Bacterial Sepsis
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Fungal Sepsis
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Sepsis Diagnostic Market, By Product
9.1. Sepsis Diagnostic Market, By Filling Material, 2020-2027
9.1.1. Instruments
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Blood Culture Media
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Assay Kits and Reagents
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Software
9.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Sepsis Diagnostic Market, By Testing Type
10.1. Sepsis Diagnostic Market, By End-use, 2020-2027
10.1.1. Laboratory Testing
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. PoC Testing
10.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Sepsis Diagnostic Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.1.3. Market Revenue and Forecast, By Product(2016-2027)
11.1.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.5.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.1.5.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.6.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.1.6.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.2.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.5.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.5.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.6.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.7.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.7.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.8.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.8.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.3.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.5.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.5.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.6.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.6.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.7.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.7.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.8.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.8.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.4.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.5.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.5.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.6.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.6.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.7.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.7.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.8.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.8.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.5.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.5.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.5.5.4. Market Revenue and Forecast, By Testing Type(2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.6.2. Market Revenue and Forecast, Pathogen (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.5.6.4. Market Revenue and Forecast, By Testing Type(2016-2027)
Chapter 12. Company Profiles
12.1. bioMérieux SA
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Beckman Coulter, Inc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Becton, Dickinson and Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Sysmex Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. F. Hoffmann-La Roche AG
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Thermo Fisher Scientific, Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms